By Heather Blumenthal A study into how to make healthcare decision makers willing to fund new and costly CAR T therapy for leukemia by building cost considerations into the research process has led Kednapa Thavorn to an important conclusion: efforts to develop a made-in-Canada CAR T therapy are worth pursuing. Dr. Thavorn,… Read more »
Category: News
Where Are They Now: Jessica Silva
At BioCanRx, we are incredibly proud of our HQP and their dedication to cancer immunotherapy research. Whether they are working on viruses in the lab or examining the socioeconomic barriers to adopting certain treatments in Canada, each one plays a unique role in strengthening our network and expertise in immunotherapy. BioCanRx is invested in… Read more »
Examining CAR-T therapy, person by person
Time for a pop quiz: Who responds better to CAR-T therapy? Men or women? What dose of the therapy works best? A low dose? Medium? A high dose? Those are just two of the questions Dean Fergusson of the Ottawa Hospital Research Institute (OHRI) has been trying to answer by… Read more »
2023 Cohort of BioCanRx Summer Students
Introducing the winners of BioCanRx’s 2023 Summer Studentships BioCanRx is happy to introduce the 16 undergraduate students chosen from across Canada through a competitive application process to be part of our Summer Student Internship Program. The program’s goal is to inspire the next generation of highly qualified personnel to pursue research or policy-related… Read more »
Summit4CI Registration Now Open!
Please join us Sunday, October 1 to Wednesday, October 4 as we explore the latest progress in cancer immunotherapy from scientific, clinical, industry and patient perspectives during BioCanRx’s seventh scientific conference. The 2023 Summit for Cancer Immunotherapy (Summit4CI) will take place in Ottawa, Ontario, at the Fairmont Château Laurier. Join more than 300 scientists,… Read more »
From a project to a platform: A new and less expensive way to deliver immunotherapy
By Heather Blumenthal In fall, 2020, in an earlier article in this newsletter, Carolina Ilkow described exosomes as a “FedEx system” for cells. At the time, she was leading a BioCanRx-funded Enabling Grant examining how the same oncolytic virus could be used in many people to “train” a patient’s immune system to fight that… Read more »
Sharing Insights on International Day of Women and Girls in Science
On International Day of Women and Girls in Science 2023, we asked women in the BioCanRx Network to share their opinions, knowledge, and advice through a series of questions relating to women in science. Read on for their important insights! “Science represents a search for knowledge – many times to improve the world…. Read more »
World Cancer Day Message from BioCanRx
Closing the Cancer Care Gap Today, more than ever, the state of healthcare in Canada is front and centre. Fair access to timely and high-quality care that enables people to manage their own health and that of their loved ones is an intrinsically Canadian value. Cancer, and its devastatingly widespread effects, is the largest… Read more »
Where Are They Now: Nikolas Martin
At BioCanRx, we are incredibly proud of our HQP and their dedication to cancer immunotherapy research. Whether they are working on viruses in the lab or examining the socioeconomic barriers to adopting certain treatments in Canada, each one plays a unique role in strengthening our network and expertise in immunotherapy. BioCanRx is invested in… Read more »
Both Sides of the Learning Institute 2022 Experience
Participation from a Patient/Caregiver Perspective By: Don Wood, Caregiver and Patient Engagement in Research Advocate and BioCanRx 2022 Patient Scholar Long before meeting in person in Montreal, November 19-21, for the BioCanRx Summit for Cancer Immunotherapy (Summit4CI). There was pre-work and training classes to take as a Patient Scholar such as Cancer… Read more »
